Skip to main content
. 2013 May 7;6:187. doi: 10.1186/1756-0500-6-187

Table 4.

Comparison of ART outcomes after 1 year between those with one or more worries and those without any worry at the first eligibility assessment

ART outcomes Worries reported at assessment for ART eligibility
No worry
One worry or more
Specific worries
 
 
HIV status disclosure
Nutrition
Condoms use
Use of other medication
ART Adherence
ART side effects
n=104 n=195 n=54 n=38 n=23 n=26 n=19 n=19
Total with CD4 counts after ART eligibility
63
134
32
22
14
18
15
11
Mean CD4 counts increase (per year) (95% CI)
162
199
112
127
97
363
189
156
(112-211)
(129-270)
(80-145)
(87-167)
(42-151)
(-19-746)
(56-322)
(-31-343)
Median CD4 increase
92
114
73
112
74
122
115
168
(IQR)
(47-212)
(41-213)
(41-183)
(46-215)
(40-106)
(59-210)
(33-232)
(73-237)
Total with viral loads
54
126
33
24
14
16
15
12
CD4 count > 100 after ART start
42 (78%)
95 (75%)
23 (70%)
16 (67%)
10 (71%)
10 (63%)
15 (100%)
12 (100%)
Annual decrease in median log VL (IQR)
0.01
−0.10*
−0.24*
0.04*
0.18
0.17
−0.14
0.05
(-0.10-0.12)
(-0.19 - -0.02)
(-0.41 - -0.07)
(-0.12 - -0.21)
(0.01-0.35)
(0.12 - 0.33)
(-0.49 - 0.20)
(-0.02 - 0.30)
Number who started ART
104
195
51
38
23
24
19
19
Substituted / switched ART
29 (28%)
53 (27%)
16 (31%)
7 (18%)
6 (26%)
8 (33%)
3 (16%)
7 (37%)
Died 19 (18%) 13 (7%) 5 (10%) 4 (11%) 1 (4%) 1 (4%) 0 (0) 1 (5%)

*p<0.05 Note: Comparisons are between those with one or more worries and those with no worry, and also between those with a particular worry and all those without that particular worry.